Jorgensen resigned from UK in June 2023, receiving $75,000 as he departed. At the time, he was the focus of misconduct ...

Lars Fruergaard Jørgensen began his career at Novo Nordisk as an economist in the health care, economy, and planning ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide— while adding great ...

“Honestly, I’m quite alarmed by what we see in the U.S. now,” Novo Nordisk President and CEO Lars Fruergaard Jorgensen told CNN on Wednesday. “Patients who believe that they’re getting access to a ...

CEO Lars Fruergaard Jorgensen expressed concern, stating that only Novo Nordisk makes real semaglutide and does not supply it ...

A sex abuse lawsuit against the University of Kentucky and former head swimming and diving coach Lars Jorgensen this week voluntarily dropped Jorgensen’s predecessor, Gary Conelly, as a defendant.

A sex abuse lawsuit against the University of Kentucky and former head swimming and diving coach Lars Jorgensen this week voluntarily dropped Jorgensen’s predecessor, Gary Conelly, as a defendant. On ...

They have it because it's good business. Lars Jorgensen: Yes, we did. Jon Wertheim: So if somebody says, "I'm just gonna take these anti-obesity drugs rather than come here," what would you tell them?

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...